Afelimomab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Afelimomab ?
Monoclonal antibody
Type F(ab')2 fragment
Source Mouse
Target TNFα
Clinical data
Legal status ?
Identifiers
CAS number 156227-98-4 N
ATC code L04AB03
KEGG D07436 YesY
Chemical data
Formula ?
 N (what is this?)  (verify)

Afelimomab (MAK 195F) is an anti-TNFα monoclonal antibody. Administration of afelimomab reduces the concentration of interleukin-6 in patients with sepsis, but reduces mortality only marginally.[1][2]

References[edit]

  1. ^
    1. REDIRECT Template:Cite pmid
  2. ^
    1. REDIRECT Template:Cite pmid